
GW Pharmaceuticals plc GWPH
$ 218.96
0.0%
GW Pharmaceuticals plc P/E Ratio 2011-2025 | GWPH
Annual P/E Ratio GW Pharmaceuticals plc
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -82.3 | -4.65 K | -12.4 | -15.2 | -31.8 | -24 | -51.9 | -52.7 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -12.4 | -4.65 K | -615 |
P/E Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amryt Pharma plc
AMYT
|
2.55 K | $ 14.7 | - | $ 621 M | ||
|
Aerie Pharmaceuticals
AERI
|
-4.35 | $ 15.25 | - | $ 754 M | ||
|
PetIQ
PETQ
|
186 | $ 13.6 | 1.64 % | $ 400 M | ||
|
Agile Therapeutics
AGRX
|
-0.0895 | $ 0.6 | 10.11 % | $ 58.2 M | ||
|
Teligent, Inc.
TLGT
|
-0.879 | $ 0.173 | -13.85 % | $ 16.1 M | ||
|
Recro Pharma
REPH
|
-10 | $ 1.4 | -4.76 % | $ 65.3 M | ||
|
Athenex
ATNX
|
-0.111 | $ 0.2 | -23.39 % | $ 1.76 M | ||
|
PLx Pharma
PLXP
|
-2.56 | $ 0.09 | -27.8 % | $ 2.56 M | ||
|
Shineco, Inc.
TYHT
|
-1.99 | $ 11.09 | -3.90 % | $ 97.2 M | ||
|
Organogenesis Holdings
ORGO
|
482 | $ 4.19 | -2.1 % | $ 552 M | ||
|
Lannett Company
LCI
|
-0.108 | $ 0.66 | 1.15 % | $ 7.11 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-1.9 | $ 40.0 | -0.1 % | $ 2.03 B | ||
|
ProPhase Labs
PRPH
|
7.07 | $ 0.39 | 2.61 % | $ 6.18 M | ||
|
Adamas Pharmaceuticals, Inc.
ADMS
|
-2.85 | $ 8.22 | - | $ 376 M | ||
|
Dr. Reddy's Laboratories Limited
RDY
|
0.625 | $ 14.6 | 0.9 % | $ 2.42 B | ||
|
Flexion Therapeutics, Inc.
FLXN
|
-4.58 | $ 9.12 | - | $ 459 M | ||
|
SCYNEXIS
SCYX
|
1.05 | $ 0.72 | -5.05 % | $ 34.5 M | ||
|
Happiness Biotech Group Limited
HAPP
|
1.88 | $ 4.5 | 1.35 % | $ 17.8 M | ||
|
Kindred Biosciences, Inc.
KIN
|
-9.01 | $ 9.25 | 0.11 % | $ 419 M | ||
|
Sanofi
SNY
|
9.99 | $ 51.06 | -0.68 % | $ 66.8 B | ||
|
Supernus Pharmaceuticals
SUPN
|
24.4 | $ 53.17 | 0.85 % | $ 2.93 B | ||
|
Neos Therapeutics, Inc.
NEOS
|
-4.77 | $ 1.15 | -2.54 % | $ 57.2 M | ||
|
Endo International plc
ENDP
|
-0.0278 | $ 0.29 | - | $ 28.9 M | ||
|
Tricida
TCDA
|
-2.03 | $ 0.11 | - | $ 3.25 M | ||
|
Tilray
TLRY
|
-0.821 | $ 1.38 | -6.12 % | $ 853 M | ||
|
PPD, Inc.
PPD
|
71.4 | $ 47.25 | 0.13 % | $ 16.6 B | ||
|
Bausch Health Companies
BHC
|
-5.71 | $ 6.19 | -0.24 % | $ 2.26 B | ||
|
HEXO Corp.
HEXO
|
-0.775 | $ 0.71 | 2.45 % | $ 38.1 M | - | |
|
Veru
VERU
|
-2.85 | $ 3.65 | -3.95 % | $ 492 M | ||
|
Neptune Wellness Solutions
NEPT
|
-92.1 | $ 0.2 | -45.3 % | $ 917 K | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
23.3 | $ 42.97 | - | $ 1.62 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
48.4 | $ 116.3 | - | $ 26.6 B | ||
|
Viatris
VTRS
|
6.55 | $ 10.29 | -1.25 % | $ 12.5 B | ||
|
FSD Pharma
HUGE
|
-0.457 | $ 5.84 | 5743.5 % | $ 69.7 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-0.679 | $ 0.78 | 0.86 % | $ 117 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
-0.536 | $ 1.3 | - | $ 55.5 M | ||
|
Guardion Health Sciences
GHSI
|
-0.476 | $ 3.25 | -0.31 % | $ 3.64 M | ||
|
Alimera Sciences
ALIM
|
-5.04 | $ 5.54 | - | $ 142 M | ||
|
Biogen
BIIB
|
11.9 | $ 149.13 | -0.86 % | $ 21.7 B | ||
|
Qilian International Holding Group Limited
QLI
|
21.9 | $ 5.41 | -6.08 % | $ 184 M | ||
|
Amneal Pharmaceuticals
AMRX
|
-24.7 | $ 5.91 | 2.6 % | $ 892 M | - | |
|
Ironwood Pharmaceuticals
IRWD
|
266 | $ 1.54 | -5.52 % | $ 245 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-14.7 | $ 18.59 | 0.16 % | $ 1.77 B | ||
|
Perrigo Company plc
PRGO
|
-23 | $ 21.6 | -1.55 % | $ 2.97 B | ||
|
Cumberland Pharmaceuticals
CPIX
|
-46.5 | $ 3.3 | 3.45 % | $ 46.4 M | ||
|
Aurora Cannabis
ACB
|
-1.32 | $ 5.01 | -1.57 % | $ 86.3 M | - | |
|
Eagle Pharmaceuticals
EGRX
|
9.54 | $ 2.14 | -39.89 % | $ 27.7 M | ||
|
China SXT Pharmaceuticals
SXTC
|
-0.685 | $ 1.32 | 4.76 % | $ 1.88 M | ||
|
OrganiGram Holdings
OGI
|
-2.92 | $ 1.64 | -4.09 % | $ 402 M |